The interim analysis of the UK Interstitial Lung Disease Post COVID study reveals extent of lung scarring after COVID hospitalisation.

The study, launched with £2 million of funding from UKRI and led by Imperial, aims to develop treatment strategies and prevent disability

On the 4 November 2021, the Margaret Turner-Warwick Centre for Fibrosing Lung Disease (MTWC) launched.

Dr Laura Fabbri and Dr Alison John ran an activity entitled ‘Can we take your breath away?’ on behalf of the Margaret Turner Warwick Centre

Blog post of the MTWC team and APF volunteers attending the GERF 2023

How a low and controlled dose of morphine may reduce coughing from idiopathic pulmonary fibrosis